Gary Zammit, MD, president and chief executive officer of Clinilabs will present at the New England Regional Chapter Society of Quality Assurance Good Clinical Practices training.
Symbion Systems, Inc. announced that its Symbion-DX, RX, and LX Analytical Instrument Software Suites, Version 5.0, are now fully compatible with all versions of the Windows 7 operating system.
Bio-Rad Laboratories, Inc. introduces the CFX Connect real-time PCR detection system, an ideal tool for researchers looking for reliable, high performance real-time PCR on a limited budget.
A scientific imaging company has been spun out from the University of Oxford. Oxford Imaging Detectors is developing high performance scientific imaging detectors capable of studying structures and processes at the atomic level.
Aslan Pharmaceuticals Ltd. said it reached an agreement with Bristol-Myers Squibb Co. to market the company's experimental cancer drug in China, Australia, Korea and Taiwan.
Age-related macular degeneration (AMD), which is coincident with reduced choroidal blood flow, is the leading cause of blindness or visual impairment in people over 50.
The U.S. Food and Drug Administration has approved a stent graft system that provides patients with small arteries the option of less invasive surgery to repair their potentially life-threatening abdominal aortic aneurysm.
Biotechnology company Medivation Inc. said a clinical trial of its experimental prostate cancer pill is ending earlier than expected because the study showed the drug worked.
Shares of Alkermes Plc slid while broader trading indexes climbed, as the drugmaker reported a wider fiscal second-quarter loss after completing its acquisition of Elan Corp.'s drug technology business.
Fitch Ratings said that it downgraded several debt ratings for Eli Lilly and Co. over concerns about a wave of patent expirations that will hurt the drugmaker's sales.
The Food and Drug Administration is highlighting an uptick in new drug approvals after a decade-long downturn in the number of medications approved by the agency.
Endo Pharmaceuticals Inc. said the Food and Drug Administration approved its generic version of AstraZeneca PLC's Plendil extended-release tablets.
Valeant Pharmaceuticals International Inc. said it turned a third-quarter profit as its U.S. dermatology division did better than expected and revenue swelled following its purchase by Biovail Corp.
Mayo Clinic researchers have shown that eliminating cells that accumulate with age could prevent the onset of age-related disorders and disabilities.